Tolingin, Gabrielle M.
HRN: 14-98-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2024
CEFUROXIME 1.5GM (VIAL)
10/30/2024
10/30/2024
IV
1.5g
Now
Postop Prohylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes